Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 45,000 shares at $4.24 ($194K) on 2025-12-08, disclosed to the SEC on 2025-12-08.
Open-market purchase of $194k ANVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 15,000 | $64K | 32.8% |
| 2 | $4.34 | 30,000 | $130K | 67.2% |
| Total | $4.31 avg | 45,000 | $194K | 100% |
| Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |
| ANVS | BUY | 2025-11-18 | $32K | — | Filing → |